LGALS3BP and Hepatic fibrosis: Recently, M2BPGi, an altered form of Mac-2 binding protein (M2BP) due to changes in the N-glycosylation during the progression of hepatic fibrosis, has been reported as a novel biomarker for liver fibrosis [7].